RNA-editing oligonucleotides and uses thereof
US11479575B2 · kind B2 · utility
3Cited by
5References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2020 |
| Grant date | Oct 25, 2022 |
| Priority date | — |
| Expiry date | Jun 5, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/50
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure features useful compositions and methods to treat disorders for which deamination of an adenosine in an mRNA produces a therapeutic result, e.g., in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.